2Dr. J. T. Tamsma,J. Born,J. A. Bruijn,K. J. M. Assmann,J. J. Weening,J. H. M. Berden,J. Wieslander,E. Schrama,J. Hermans,J. H. Veerkamp,H. H. P. J. Lemkes,F. J. Woude. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane[J] 1994,Diabetologia(3):313～320
1Okazaki L,Wada N,Nakano M,et al.Difference in gene expression for matrix matalloproteinase-Ⅰ between early and advanced hepatocellular carcinomas[J].Hepatology,1997,26(6):1521.
2Arthur MJP,Murawaki Y.Serum matalloproteinase-Ⅰ in patients with chronic viral hepatitis[J].J Gastroenterol Hepatol,1999,14(2):138.
3Murawaki Y,Yamada S,Ikuta y,et al.Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease[J].J Hepatol,1999,30(6):1090.
4Murawaki Y,Ikuta Y,Idobe Y,et al.Tissue inhibitor of metalloproteinase-I in the liver of patients with chronic liver disease[J].J Hepatal,1997,26(6):1213.
5Ueno T,Tamaki S,Sugawara H,et al.Significance of serum tissue inhibitor of metalloproteinase-I in various liver disease[J].J Hepatal,1996,24:177.
6Laviades C,Varo N,Fernander J,et al.Abnormalities of the extracellular degradation of collagen type Ⅰ in essential hypertension[J].Circulation,1998,98(6):535.
